In 2016, a nomination was received for transcranial magnetic stimulation (TMS) for the treatment of psychiatric disorders.
In 2017, an update was received regarding a wearable wireless patch biosensor for observation and monitoring for patients with acute severe behavioural disturbance as an alternative to visual assessment of respiratory and vital sign status.
In 2017, an update was received for a pulse oximetry device for continuous monitoring of patients at high risk of suicide.
New health technology enquiries can be emailed to: MOH-HealthTechNominations@health.nsw.gov.au